Description
The Practicing Oncologists Working Group is pleased to present a new series of Spotlight articles featuring highlights from the ESMO 2021 Congress.
Watch the presentations and make sure you keep up to date on the key practice changing outcomes from this year's annual meeting.
Produced by the Practising Oncologists Working Group
Featured abstract
LBA3_PR - Pembrolizumab versus placebo after complete resection of high-risk stage II melanoma: Efficacy and safety results from the KEYNOTE-716 double-blind phase III trial
Presenter: Jason Luke - Session: Presidential symposium 1
Abstract, slides and webcast
Last update:
09 Dec 2021
